Cytokines as adjuvants for ruminant vaccines

International Journal for Parasitology

Volumn 26, Issue 8-9, 1996, Pages 835-842

  Lofthouse, S A ^a   Andrews, A E ^a   Elhay, M J ^a   Bowles, V M ^a   Meeusen, E N T ^a   Nash, A D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

adjuvant; cytokine; interleukin 1; interleukin 2; ruminant

Indexed keywords

GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; INTERLEUKIN 2; VACCINE;

ADJUVANT THERAPY; CATTLE; CELLULAR IMMUNITY; CONFERENCE PAPER; HUMORAL IMMUNITY; NONHUMAN; PARASITOSIS; VACCINATION; VETERINARY MEDICINE;

BACTERIA (MICROORGANISMS); BOS TAURUS; BOVINAE; OVIS; OVIS ARIES; VERMES;

EID: 0030221737     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(96)80052-X     Document Type: Conference Paper

References (57)

1. Andrews A. E., Lofthouse S. A., Bowles V. M., Brandon M. R. & Nash A. D. 1994. Production and in vivo use of recombinant ovine interleukin-1β as an immunological adjuvant. Vaccine 12: 14-24.
2. Barcham G. J., Andrews A. E. & Nash A. D. 1995. Cloning and expression of a cDNA encoding ovine interleukin-7. Gene 154: 265-269.
3. Blecha F., Reddy D. N., Chitko-McKown C. G., McVey D. S., Chengappa M. M., Goodband R. D. & Nelssen J. L. 1995. Influence of recombinant bovine interleukin-1β and interleukin-2 in pigs vaccinated and challenged with Streptococcus suis. Veterinary Immunology and Immunopathology 44: 329-346.
4. Bowles V. M., Meeuson E., Young A. R., Andrews A. E., Nash A. D. & Brandon M. R. 1995. Vaccination of sheep against larvae of the sheep blowfly (Lucilia cuprina). Vaccine, in press.
5. Cox J. C. & Coulter A. R. 1992. Advances in adjuvant technology and application. In Animal Parasite Control Utilising Biotechnology (Edited by Yong W. K.), pp 49-112. CRC Press, Boca Raton.
6. Curry A. J., Else K. J., Jones F., Bancroft A., Gencis R. K. & Dunne D. W. 1995. Evidence that cytokine mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. Journal of Experimental Medicine 181: 769-774.
7. Else K. J., Finkelman F. D., Maliszewski C. R. & Grencis R. K. 1994. Cytokine-mediated regulation of chronic intestinal helminth infection. Journal of Experimental Medicine 179: 347-351.
8. Finkelman F. D., Madden K. B., Cheever A. W., Katona I. M., Morris S. C., Gately M. K., Hubbard B. R., Gause W. C. & Urban J. F. 1994. Effects of interleukin 12 on imune responses and host protection in mice infected with intestinal nematode parasites. Journal of Experimental Medicine 179: 1563-1572.
9. Fiskerstrand C. E., Roy D. J., Green I. & Sargan D. R. 1992. Cloning, expression and characterisation of ovine interleukins Iα and β. Cytokine 4: 418-428.
10. Fujiwara T., Sakantigenami K., Matsuoka J., Shiozaki S., Fujioka K., Takada Y., Uchida S., Onoda T. & Orita K. 1991. Augmentation of anti-tumour effect on syngeneic murine solid tumours by an interleukin-2 slow delivery system, the IL-2 minipellet. Biotherapy 3: 203-209.
11. Goff J. P., Naito Y., Kehru M. E., Hayes P. & Daley M. 1992. Physiologic effects of administration of interleukin-1β in cows. American Journal of Veterinary Research 53: 1983-1987.
12. Good M. F., Pombo D., Lunde M. N., Maloy W. L., Halenbeck R., Koths K, Miller L. H. & Berzofsky J. A. 1988. Recombinant human IL-2 overcomes genetic non-responsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2. Journal of Immunology 141: 972-977.
13. Graham M., Smith T. S., Munn E. A., Knox D. P., Oliver J. J. & Newton S. E. 1993. Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections. Patent no. WO 93/23542.
14. Green I. R., Fiskerstrand C., Bertoni G., Roy D. J., Peterhans E. & Sargan D. R. 1993. Expression and characterisation of bioactive recombinant ovine TNFα: some species specificity in cytotoxic response to TNF. Cytokine 5: 213-223.
15. Grun J. L. & Maurer P. H. 1989. Different T helper cell subsets elicited in mice utilising two different adjuvant vehicles: the role of endogenous interleukin-1 in proliferative responses. Cellular Immunology 121: 135-145.
16. Gupta R. K. & Relyveld E. H. 1991. Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components of the vaccine. Vaccine 9: 699-702.
17. Gupta R. J., Relyveld E. H., Lindblad E. B., Bizzini B., Ben-Effraim B. & Gupta C. K. 1993. Adjuvants-a balance between toxicity and adjuvanticity. Vaccine 11: 293-306.
18. Heath A. W., Haque N. A., deSouza J. B. & Playfair J. H. L. 1989a. Interferon gamma as an effective immunological adjuvant. In Vaccines 89: 43-46. Cold Spring Harbour Laboratories, New York.
19. Heath A. W., Devy M. E., Brown I. N., Richards C. E. & Playfair J. H. L. 1989. Interferon gamma as an adjuvant in immunocompromised mice. Immunology 67: 520-524.
20. Heath A. W. & Playfair J. H. L. 1991. Effects of added cytokines on immune response and memory. In Vaccines (Edited by G. Gregoriadis), pp. 77-84. Plenum Press, New York.
21. Ho R. J. Y., Burke R. L. & Merigan T. C., 1992. Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea pigs. Vaccine 10: 209-213.
22. Holland G. P., Holland N. & Steward M. W. 1990. Interferon gamma potentiates antibody affinity in mice with a genetically controlled defect in affinity maturation. Clinical and Experimental Immunology 82: 221-226.
23. Hughes H. P. A., Campos M., Godson P. L., Van Drunen Littel -Van Denhurk S., McDougall L., Rapin N., Zamb T. & Babuik L. A. 1991. Immunopotentiation of bovine herpes virus subunit vaccination by interleukin-2. Immunology 74: 461-466.
24. Hughes H. P. A., Campos M., Van Drunen Littel-Van Denhurk S., Zamb T., Sordillo L. M., Godson D. & Babuik L. A. 1992. Multiple administration of interleukin-2 potentiates antigen-specific responses to subunit vaccination with bovine herpes virus-1 glycoprotein IV. Vaccine 10: 226-230.
25. Joffret M. L., Morgeaux S., LeClerc C., Oth D., Zanetti C., Sureau P. & Perrin P. 1990. Enhancement of interleukin-2 activity by liposomes. Vaccine 8: 385-389.
26. Katre N. V., Knauf M. J. & Laird W. J. 1987. Chemical modification of recombinant interleukin 2 by polethylene glycol increases its potency in the murine Meth A sarcoma model. Proceedings of the National Acadamy of Science USA 84: 1487-1491.
27. Kullberg M. C., Pearce E. J., Hieny S. A., Sher A. & Berzofsky J. A. 1992. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. Journal of Immunology 148: 3264-3270.
28. Lise L. & Audibert F. 1989. Immunoadjuvants and analogues of immunomodulatory bacterial structures. Current Opinions in Immunology 2: 269-274.
29. Lofthouse S. A., Andrews A. E., Nash A. D. & Bowles V. M. 1995. Humoral and cellular responses to intradermally administered cytokine and conventional adjuvants. Vaccine 13: 1131-1137.
30. Lofthouse S. A., Andrews A. E., Barcham G. J. & Nash A. D. 1995. Parameters related to the application of recombinant ovine interleukin-1β as an adjuvant. Vaccine (Adjuvant Research) 13: 1277-1287.
31. Martin H. M., Nash A. D. & Andrews A. E. 1995. Cloning and characterisation of an ovine interleukin-10-encoding cDNA. Gene 159: 187-191.
32. McInnes C., Haig D. & Logan M. 1993. The cloning and expression of the gene for ovine interleukin 3 (multi-CSF) and a comparison of the in vitro hematopoietic activity of ovine IL-3 with ovine GM-CSF and human M-CSF. Experimental Hematology 21: 1528-1534.
33. Morikawa K., Okada F., Hosokawa M. O. & Koboyashi H. 1987. Enhancement of the therapeutic effects of recombinant interleukin-2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle, pluronic gel. Cancer Research 47: 37-41.
34. Morris A. G. 1988. Interferons. Immunology Suppl. 1, pp. 43-45.
35. Mosmann T. R. & Coffman R. L. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Advances in Immunology 46: 111-142.
36. Munn E. A., Smith T. S., Graham S., Tavernor A. S. & Greenwood C. A. 1993. The potential value of integral membrane proteins in vaccination of lambs against Haemonchus contortus. International Journal for Parasitology 23: 261-269.
37. Nash A. D., Lofthouse S. A., Barcham G. J., Jacobs H. J., Ashman K., Meeusen E. N. T.. Brandon M. R. & Andrews A. E. 1993. Recombinant cytokines as immunological adjuvants. Immunology and Cell Biology 71: 367-379.
38. Newton S. E. 1995. Progress on vaccination against Haemonchus contortus. International Journal for Parasitology, in press.
39. Nunberg J. H., Doyle M. V., York S. M. & York C. J. 1989. Interleukin-2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proceedings of the National Acadamy of Science U.S.A. 86: 4240-4243.
40. Playfair J. H. L. & deSouza J. B. 1987. Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clinical and Experimental Immunology 67: 5-10.
41. Ramon G. 1926. Procedes pour accroitre 1a production des antitoxines. Annals Institute of Pasteur 40: 1-10.
42. Reddy P. G., Blecha F., Minocha H. C., Anderson G. A., Morrill J. I., Fedorka-Cray P. J. & Baker P. E. 1989. Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infection. Veterinary Immunology and Immunopathology 23: 61-74.
43. Reddy D. N., Reddy P. G., Minocha H. C., Fenwick B. W., Baker P. E., Davis W. C. & Blecha F. 1990. Adjuvanticity of recombinant interleukin-1b: influence on immunity, infection and latency in a bovine herpes virus-1 infection. Lymphokine Research 9: 295-307.
44. Reddy D. N., Reddy P. G., Xue W., Minocha H. C., Daley M. J., Davis W. C. & Blecha F. 1993. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1β and interleukin-2. Veterinary Immunology and Immunopathology 37: 25-38.
45. Reed S. G., Pihl D. L., Conlon P. J. & Grabstein K. H. 1989. IL-1 as adjuvant. Role of T cells in augmentation of specific antibody production by recombinant human IL-1α. Journal of Immunology 142: 3129-3133.
46. Rosa F. & Fellous M. 1984. The effect of gamma interferon on MHC Antigens. Immunology Today 5: 261-262.
47. Rouse B. T., Miller L. S., Turtinen L. & Morre R. N. 1985. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin-2. Journal of Immunology 134: 926-930.
48. Sagara T., Mori S., Ohkawara S., Goto F., Takagi K. & Yoshinaga M. 1990. A limited role of IL-1 in immune-enhancement by adjuvants. Immunology 71: 251-258.
49. Seow H. F., Rothel J. S. & Wood P. R. 1994. Expression and purification of recombinant ovine interleukin 1β from E. Coli. Veterinary Immunology and Immunopathology 41: 229-239.
50. Seow H. F., Yoshimura T., Wood P. R. & Colditz I. G. 1994. Cloning, sequencing, expression and inflammatory activity in skin of ovine interleukin-8. Immunology and Cell Biology 72: 398-405.
51. Singh-Hora M., Rana R. K., Nunberg J. H., Tice T. R., Gilley R. M. & Hudson M. E. 1990. Controlled release of interleukin-2 from biodegradable microspheres. Biotechnology 8: 755-758.
52. Smith N. C. 1992. Concepts and strategies for anti-parasite immunoprophylaxis and therapy. International Journal for Parasitology 22: 1047-1082.
53. Staruch M. W. & Wood D. D. 1983. The adjuvanticity of interleukin-1 in vivo. Journal of Immunology 130: 2191-2194.
54. Stewart-Tull D. E. S. 1991. The assessment and use of adjuvants. In Vaccines (Edited by G. Gregoriadis), pp. 85-92. Plenum Press, New York.
55. Tavernor A. S., Smith T. S., Langford C. F., Munn E. A. & Graham M. 1992. Vaccination of young Dorset lambs against haemonchosis. Parasite Immunology 14: 671-675.
56. Tuckwell K. R. (Ed). 1993. Index of Veterinary Specialities. MIMS Australia, Sydney.
57. Weinberg A. & Merigan T. C. 1988. Recombinant interleukin-2 as an adjuvant for vaccine-induced protection. Journal of Immunology 140: 294-299.